Literature DB >> 33321006

Celiac disease and COVID-19 pandemic: should we worry?

Y Gokden1, S Hot2, M Adas3, D Ogutmen Koc4, S Atak3, A B Hot5.   

Abstract

BACKGROUND AND STUDY AIMS: The Coronavirus Disease 2019 (COVID-19) epidemic especially worries people with chronic diseases the entire world. In this study, the frequency, and clinical course of COVID-19 infection in patients with Celiac disease (CD) were investigated. CD patients' adherence to purchasing gluten free products (GFPs), the strict diet, and how patients' anxiety affects CD symptoms during the COVID-19 outbreak were also examined. PATIENTS AND METHODS: A detailed questionnaire was administered by telephone and emailed to the CD patients to determine the status of these patients in obtaining GFPs, and dietary compliance during the COVID-19 pandemic. State and trait anxiety levels of patients were evaluated using the State-trait Anxiety Inventory (STAI) scale. Additionally, whether patients with CD were diagnosed with COVID-19, and if diagnosed, their clinical course of the disease were investigated.
RESULTS: One hundred and one patients were included in the study. The total number of patients who could obtain GFPs decreased significantly in the pandemic than before the pandemic. The patients' state anxiety index was 40.7±7.9, and the trait anxiety index was 44.5±8.5, and all patients were evaluated as mildly anxious. During the pandemic, two female patients were diagnosed with COVID-19.
CONCLUSION: CD patients did not have any additional risk compared to other individuals in terms of becoming infected with COVID-19 for patients under gluten free diet, and these patients will have a similar clinical course as individuals without CD. © Acta Gastro-Enterologica Belgica.

Entities:  

Keywords:  Celiac disease: COVID-19; anxiety; gluten free diet

Mesh:

Year:  2020        PMID: 33321006

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  5 in total

1.  Prevalence and outcome of COVID-19 among Iranian celiac patients.

Authors:  Fahimeh Sadat Gholam-Mostafaei; Nastaran Asri; Naser Parvani; Elham Aghamohammadi Khamene; Farnoosh Barzegar; Mohammad Rostami-Nejad; Mostafa Rezaei-Tavirani; Bijan Shahbazkhani; Somayeh Jahani-Sherafat; Kamran Rostami; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2022

2.  Toward finding the difference between untreated celiac disease and COVID-19 infected patients in terms of CD4, CD25 (IL-2 Rα), FOXP3 and IL-6 expressions as genes affecting immune homeostasis.

Authors:  Nastaran Asri; Ehsan Nazemalhosseini Mojarad; Hamed Mirjalali; Seyed Reza Mohebbi; Kaveh Baghaei; Mohammad Rostami-Nejad; Abbas Yadegar; Mostafa Rezaei-Tavirani; Hamid Asadzadeh Aghdaei; Kamran Rostami; Andrea Masotti
Journal:  BMC Gastroenterol       Date:  2021-12-11       Impact factor: 3.067

3.  Celiac disease in the COVID-19 pandemic.

Authors:  Gabriel Samasca; Aaron Lerner
Journal:  J Transl Autoimmun       Date:  2021-08-31

4.  Health-Related Quality of Life and Experiences of Brazilian Celiac Individuals over the Course of the Sars-Cov-2 Pandemic.

Authors:  Ana Luísa Falcomer; Priscila Farage; Cláudia B Pratesi; Riccardo Pratesi; Lenora Gandolfi; Eduardo Yoshio Nakano; António Raposo; Renata Puppin Zandonadi
Journal:  Nutrients       Date:  2021-05-09       Impact factor: 5.717

5.  The Impact of the First 2020 COVID-19 Lockdown on the Metabolic Control of Patients with Phenylketonuria.

Authors:  Dariusz Walkowiak; Bożena Mikołuć; Renata Mozrzymas; Łukasz Kałużny; Bożena Didycz; Joanna Jaglowska; Danuta Kurylak; Jarosław Walkowiak
Journal:  Nutrients       Date:  2021-06-12       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.